BCL11B regulates sutural patency in the mouse craniofacial skeleton

Developmental Biology

Volumn 415, Issue 2, 2016, Pages 251-260

  Kyrylkova, Kateryna ^a,d   Iwaniec, Urszula T ^b   Philbrick, Kenneth A ^a   Leid, Mark ^a,c  

^a H   (United States)

^b OREGON STATE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d Institute OfCardiometabolism and Nutrition   (France)

Author keywords

BCL11B CTIP2; Craniofacial development; Craniosynostosis; Fgfr2c; Midfacial hypoplasia; Runx2; Twist1

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR LIGAND; LIGAND; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BCL11B; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG; BCL11B PROTEIN, MOUSE; FGFR2 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR RECEPTOR 2; REPRESSOR PROTEIN; RUNX2 PROTEIN, MOUSE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; CALVARIA; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CRANIAL SUTURE; CRANIOFACIAL DEVELOPMENT; CRANIOFACIAL SYNOSTOSIS; EMBRYO; FACIAL BONE; FGFR2C GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; MESENCHYME; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOPROGENITOR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; RUNX2 GENE; SKULL DEVELOPMENT; ANIMAL; CYTOLOGY; DEFICIENCY; DIAGNOSTIC IMAGING; EMBRYOLOGY; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; MESODERM; METABOLISM; NEURAL CREST; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKULL;

ANIMALS; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CRANIAL SUTURES; CRANIOSYNOSTOSES; FACIAL BONES; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MESODERM; MICE; MICE, KNOCKOUT; NEURAL CREST; OSTEOBLASTS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; REPRESSOR PROTEINS; SKULL; TUMOR SUPPRESSOR PROTEINS;

EID: 84951087398     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2015.10.010     Document Type: Article

References (51)

1. Behr B., Leucht P., Longaker M.T., Quarto N. Fgf-9 is required for angiogenesis and osteogenesis in long bone repair. Proc. Natl. Acad. Sci. USA 2010, 107:11853-11858.
2. Chim H., Manjila S., Cohen A.R., Gosain A.K. Molecular signaling in pathogenesis of craniosynostosis: the role of fibroblast growth factor and transforming growth factor-beta. Neurosurg. Focus 2011, 31:E7.
3. Cunningham M.L., Seto M.L., Ratisoontorn C., Heike C.L., Hing A.V. Syndromic craniosynostosis: from history to hydrogen bonds. Orthod. Craniofac. Res. 2007, 10:67-81.
4. Danielian P.S., Muccino D., Rowitch D.H., Michael S.K., McMahon A.P. Modification of gene activity in mouse embryos in utero by a tamoxifen-inducible form of Cre recombinase. Curr. Biol. 1998, 8:1323-1326.
5. el Ghouzzi V., Le Merrer M., Perrin-Schmitt F., Lajeunie E., Benit P., Renier D., Bourgeois P., Bolcato-Bellemin A.L., Munnich A., Bonaventure J. Mutations of the TWIST gene in the Saethre-Chotzen syndrome. Nat. Genet. 1997, 15:42-46.
6. Eswarakumar V.P., Horowitz M.C., Locklin R., Morriss-Kay G.M., Lonai P. A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc. Natl. Acad. Sci. USA 2004, 101:12555-12560.
7. Fitzpatrick D.R. Filling in the gaps in cranial suture biology. Nat. Genet. 2013, 45:231-232.
8. Golonzhka O., Liang X., Messaddeq N., Bornert J.M., Campbell A.L., Metzger D., Chambon P., Ganguli-Indra G., Leid M., Indra A.K. Dual role of COUP-TF-interacting protein 2 in epidermal homeostasis and permeability barrier formation. J. Investig. Dermatol. 2009, 129:1459-1470.
9. Greenwald J.A., Mehrara B.J., Spector J.A., Warren S.M., Fagenholz P.J., Smith L.E., Bouletreau P.J., Crisera F.E., Ueno H., Longaker M.T. In vivo modulation of FGF biological activity alters cranial suture fate. Am. J. Pathol. 2001, 158:441-452.
10. Hajihosseini M.K., Duarte R., Pegrum J., Donjacour A., Lana-Elola E., Rice D.P., Sharpe J., Dickson C. Evidence that Fgf10 contributes to the skeletal and visceral defects of an Apert syndrome mouse model. Dev. Dyn. 2009, 238:376-385.
11. Harada M., Murakami H., Okawa A., Okimoto N., Hiraoka S., Nakahara T., Akasaka R., Shiraishi Y., Futatsugi N., Mizutani-Koseki Y., Kuroiwa A., Shirouzu M., Yokoyama S., Taiji M., Iseki S., Ornitz D.M., Koseki H. FGF9 monomer-dimer equilibrium regulates extracellular matrix affinity and tissue diffusion. Nat. Genet. 2009, 41:289-298.
12. Holmes G., van Bakel H., Zhou X., Losic B., Jabs E.W. BCL11B expression in intramembranous osteogenesis during murine craniofacial suture development. Gene Expr. Patterns 2015, 17:16-25.
13. Iseki S., Wilkie A.O., Heath J.K., Ishimaru T., Eto K., Morriss-Kay G.M. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 1997, 124:3375-3384.
14. Jiang X., Iseki S., Maxson R.E., Sucov H.M., Morriss-Kay G.M. Tissue origins and interactions in the mammalian skull vault. Dev. Biol. 2002, 241:106-116.
15. Kim H.J., Kim J.H., Bae S.C., Choi J.Y., Ryoo H.M. The protein kinase C pathway plays a central role in the fibroblast growth factor-stimulated expression and transactivation activity of Runx2. J. Biol. Chem. 2003, 278:319-326.
16. Kim H.J., Lee M.H., Park H.S., Park M.H., Lee S.W., Kim S.Y., Choi J.Y., Shin H.I., Ryoo H.M. Erk pathway and activator protein 1 play crucial roles in FGF2-stimulated premature cranial suture closure. Dev. Dyn. 2003, 227:335-346.
17. Kim H.J., Rice D.P., Kettunen P.J., Thesleff I. FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 1998, 125:1241-1251.
18. Komori T. Regulation of osteoblast differentiation by Runx2. Adv. Exp. Med. Biol. 2010, 658:43-49.
19. Komori T., Yagi H., Nomura S., Yamaguchi A., Sasaki K., Deguchi K., Shimizu Y., Bronson R.T., Gao Y.H., Inada M., Sato M., Okamoto R., Kitamura Y., Yoshiki S., Kishimoto T. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 1997, 89:755-764.
20. Kyryachenko S., Kyrylkova K., Leid M., Kioussi C. Immunohistochemistry and detection of proliferating cells by BrdU. Methods Mol. Biol. 2012, 887:33-39.
21. Kyrylkova K., Kyryachenko S., Biehs B., Klein O., Kioussi C., Leid M. BCL11B regulates epithelial proliferation and asymmetric development of the mouse mandibular incisor. PLoS One 2012, 7:e37670.
22. Kyrylkova K., Kyryachenko S., Kioussi C., Leid M. Determination of gene expression patterns by in situ hybridization in sections. Methods Mol. Biol. 2012, 887:23-31.
23. Liu Z., Xu J., Colvin J.S., Ornitz D.M. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev. 2002, 16:859-869.
24. Montero A., Okada Y., Tomita M., Ito M., Tsurukami H., Nakamura T., Doetschman T., Coffin J.D., Hurley M.M. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Investig. 2000, 105:1085-1093.
25. Nagayama T., Okuhara S., Ota M.S., Tachikawa N., Kasugai S., Iseki S. FGF18 accelerates osteoblast differentiation by upregulating Bmp2 expression. Congenit Anom. (Kyoto) 2013, 53:83-88.
26. Nelson D.K., Williams T. Frontonasal process-specific disruption of AP-2alpha results in postnatal midfacial hypoplasia, vascular anomalies, and nasal cavity defects. Dev. Biol. 2004, 267:72-92.
27. Nie X. Cranial base in craniofacial development: developmental features, influence on facial growth, anomaly, and molecular basis. Acta Odontol. Scand. 2005, 63:127-135.
28. Nie X., Luukko K., Kettunen P. FGF signalling in craniofacial development and developmental disorders. Oral Dis. 2006, 12:102-111.
29. Ohbayashi N., Shibayama M., Kurotaki Y., Imanishi M., Fujimori T., Itoh N., Takada S. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 2002, 16:870-879.
30. Opperman L.A. Cranial sutures as intramembranous bone growth sites. Dev. Dyn. 2000, 219:472-485.
31. Ornitz D.M., Itoh N. Fibroblast growth factors. Genome Biol. 2001, 2. (REVIEWS3005).
32. Otto F., Thornell A.P., Crompton T., Denzel A., Gilmour K.C., Rosewell I.R., Stamp G.W., Beddington R.S., Mundlos S., Olsen B.R., Selby P.B., Owen M.J. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 1997, 89:765-771.
33. Park O.J., Kim H.J., Woo K.M., Baek J.H., Ryoo H.M. FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization. J. Biol. Chem. 2010, 285:3568-3574.
34. Paznekas W.A., Cunningham M.L., Howard T.D., Korf B.R., Lipson M.H., Grix A.W., Feingold M., Goldberg R., Borochowitz Z., Aleck K., Mulliken J., Yin M., Jabs E.W. Genetic heterogeneity of Saethre-Chotzen syndrome, due to TWIST and FGFR mutations. Am. J. Hum. Genet. 1998, 62:1370-1380.
35. Pietri T., Eder O., Blanche M., Thiery J.P., Dufour S. The human tissue plasminogen activator-Cre mouse: a new tool for targeting specifically neural crest cells and their derivatives in vivo. Dev. Biol. 2003, 259:176-187.
36. Potter A.B., Rhodes J.L., Vega R.A., Ridder T., Shiang R. Gene expression changes between patent and fused cranial sutures in a nonsyndromic craniosynostosis population. Eplasty 2015, 15:e12.
37. Purushothaman R., Cox T.C., Maga A.M., Cunningham M.L. Facial suture synostosis of newborn Fgfr1(P250R/+) and Fgfr2(S252W/+) mouse models of Pfeiffer and Apert syndromes. Birth Defects Res. A: Clin. Mol. Teratol. 2011, 91:603-609.
38. Rice D.P. Developmental anatomy of craniofacial sutures. Front. Oral Biol. 2008, 12:1-21.
39. Rice D.P., Aberg T., Chan Y., Tang Z., Kettunen P.J., Pakarinen L., Maxson R.E., Thesleff I. Integration of FGF and TWIST in calvarial bone and suture development. Development 2000, 127:1845-1855.
40. Rice D.P., Rice R., Thesleff I. Fgfr mRNA isoforms in craniofacial bone development. Bone 2003, 33:14-27.
41. Rosenberg P., Arlis H.R., Haworth R.D., Heier L., Hoffman L., LaTrenta G. The role of the cranial base in facial growth: experimental craniofacial synostosis in the rabbit. Plast. Reconstr. Surg. 1997, 99:1396-1407.
42. Sharma V.P., Fenwick A.L., Brockop M.S., McGowan S.J., Goos J.A., Hoogeboom A.J., Brady A.F., Jeelani N.O., Lynch S.A., Mulliken J.B., Murray D.J., Phipps J.M., Sweeney E., Tomkins S.E., Wilson L.C., Bennett S., Cornall R.J., Broxholme J., Kanapin A., Johnson D., Wall S.A., van der Spek P.J., Mathijssen I.M., Maxson R.E., Twigg S.R., Wilkie A.O. Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat. Genet. 2013, 45:304-307.
43. Sheikh F., Fandrich R.R., Kardami E., Cattini P.A. Overexpression of long or short FGFR-1 results in FGF-2-mediated proliferation in neonatal cardiac myocyte cultures. Cardiovasc. Res. 1999, 42:696-705.
44. Stewart R.E., Dixon G., Cohen A. The pathogenesis of premature craniosynostosis in acrocephalosyndactyly (Apert's syndrome). A reconsideration. Plast. Reconstr. Surg. 1977, 59:699-707.
45. Turner N., Lambros M.B., Horlings H.M., Pearson A., Sharpe R., Natrajan R., Geyer F.C., van Kouwenhove M., Kreike B., Mackay A., Ashworth A., van de Vijver M.J., Reis-Filho J.S. Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets. Oncogene 2010, 29:2013-2023.
46. Twigg S.R., Kan R., Babbs C., Bochukova E.G., Robertson S.P., Wall S.A., Morriss-Kay G.M., Wilkie A.O. Mutations of ephrin-B1 (EFNB1), a marker of tissue boundary formation, cause craniofrontonasal syndrome. Proc. Natl. Acad. Sci. USA 2004, 101:8652-8657.
47. Twigg S.R., Vorgia E., McGowan S.J., Peraki I., Fenwick A.L., Sharma V.P., Allegra M., Zaragkoulias A., Sadighi Akha E., Knight S.J., Lord H., Lester T., Izatt L., Lampe A.K., Mohammed S.N., Stewart F.J., Verloes A., Wilson L.C., Healy C., Sharpe P.T., Hammond P., Hughes J., Taylor S., Johnson D., Wall S.A., Mavrothalassitis G., Wilkie A.O. Reduced dosage of ERF causes complex craniosynostosis in humans and mice and links ERK1/2 signaling to regulation of osteogenesis. Nat. Genet. 2013, 45:308-313.
48. Wilkie A.O., Byren J.C., Hurst J.A., Jayamohan J., Johnson D., Knight S.J., Lester T., Richards P.G., Twigg S.R., Wall S.A. Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis. Pediatrics 2010, 126:e391-e400.
49. Xiao G., Jiang D., Gopalakrishnan R., Franceschi R.T. Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J. Biol. Chem. 2002, 277:36181-36187.
50. Yen H.Y., Ting M.C., Maxson R.E. Jagged1 functions downstream of Twist1 in the specification of the coronal suture and the formation of a boundary between osteogenic and non-osteogenic cells. Dev. Biol. 2010, 347:258-270.
51. Yoshida T., Vivatbutsiri P., Morriss-Kay G., Saga Y., Iseki S. Cell lineage in mammalian craniofacial mesenchyme. Mech. Dev. 2008, 125:797-808.